Work

Baseline Urinary PGE-M Is a Prognostic and Predictive Marker for Cox-2 Inhibition in Addition to Standard Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC): CALGB 30801 (Alliance)

Year: 2014

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2014.08.219

Authors: M.J. Edelman, X. Wang, L. Hodgson, G.L. Milne, R. Cheney, M. Baggstrom, T. Sachdev, A. Gajra, E. Bertino, K. Reckamp, J. Molina, J. Schiller, K. Mitchell-Richards, P. Friedman, J. Ritter, E. Vokes

Institutions: University of New Mexico, Duke University, Vanderbilt University, Roswell Park Comprehensive Cancer Center, Washington University in St. Louis, Illinois CancerCare, SUNY Upstate Medical University, The Ohio State University Wexner Medical Center, City Of Hope National Medical Center, Mayo Clinic, The University of Texas Southwestern Medical Center, Yale University, University of Chicago, University of Minnesota

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2023474794

FWCI: 0.227

Cites:

Cited by: 2

Related to: 10